Clinical trials
Phase 2 Recurrence trials in Japan
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 5 |
| Recruiting | 3 |
| Terminated | 2 |
| Not yet recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 5 |
| Celgene | 3 |
| Pfizer | 3 |
| AstraZeneca | 1 |
| Celgene Corporation | 1 |
| Eisai Co., Ltd. | 1 |
| Genmab | 1 |
| Haihe Biopharma Co., Ltd. | 1 |
| Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 1 |
| Kissei Pharmaceutical Co., Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Recurrence | 21 |
| Multiple Myeloma | 5 |
| Lymphoma, Follicular | 4 |
| Lymphoma, Large B-Cell, Diffuse | 4 |
| Lymphoma, Non-Hodgkin | 4 |
| Lymphoma, B-Cell | 3 |
| Neoplasm Metastasis | 3 |
| Lymphoma | 2 |
| Neoplasms | 2 |
| Breast Neoplasms | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.